Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Eli Lilly Dives As Zepbound Takes A Back Seat To Novo Nordisk's Wegovy At CVS
Eli Lilly Dives As Zepbound Takes A Back Seat To Novo Nordisk's Wegovy At CVS · Investor's Business Daily

In This Article:

Eli Lilly topped expectations Thursday, but shares tumbled after CVS selected Novo Nordisk's Wegovy as its preferred weight-loss drug.